Harmony Biosciences (HRMY) Competitors $32.18 -1.67 (-4.93%) Closing price 04:00 PM EasternExtended Trading$33.19 +1.01 (+3.14%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HRMY vs. ROIV, TLX, RVMD, BBIO, LEGN, AXSM, BPMC, CYTK, NUVL, and ELANShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Roivant Sciences (ROIV), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), Axsome Therapeutics (AXSM), Blueprint Medicines (BPMC), Cytokinetics (CYTK), Nuvalent (NUVL), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. Harmony Biosciences vs. Roivant Sciences Telix Pharmaceuticals Limited American Depositary Shares Revolution Medicines BridgeBio Pharma Legend Biotech Axsome Therapeutics Blueprint Medicines Cytokinetics Nuvalent Elanco Animal Health Roivant Sciences (NASDAQ:ROIV) and Harmony Biosciences (NASDAQ:HRMY) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Does the MarketBeat Community believe in ROIV or HRMY? Harmony Biosciences received 10 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 77.94% of users gave Roivant Sciences an outperform vote while only 70.00% of users gave Harmony Biosciences an outperform vote. CompanyUnderperformOutperformRoivant SciencesOutperform Votes5377.94% Underperform Votes1522.06% Harmony BiosciencesOutperform Votes6370.00% Underperform Votes2730.00% Is ROIV or HRMY more profitable? Harmony Biosciences has a net margin of 17.98% compared to Roivant Sciences' net margin of -119.54%. Harmony Biosciences' return on equity of 23.16% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-119.54% -14.05% -12.81% Harmony Biosciences 17.98%23.16%14.24% Which has more volatility & risk, ROIV or HRMY? Roivant Sciences has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, Harmony Biosciences has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Do analysts rate ROIV or HRMY? Roivant Sciences currently has a consensus target price of $18.08, suggesting a potential upside of 73.13%. Harmony Biosciences has a consensus target price of $53.11, suggesting a potential upside of 62.67%. Given Roivant Sciences' higher probable upside, equities analysts plainly believe Roivant Sciences is more favorable than Harmony Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Harmony Biosciences 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer ROIV or HRMY? In the previous week, Harmony Biosciences had 18 more articles in the media than Roivant Sciences. MarketBeat recorded 31 mentions for Harmony Biosciences and 13 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 0.76 beat Harmony Biosciences' score of 0.67 indicating that Roivant Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Harmony Biosciences 12 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in ROIV or HRMY? 64.8% of Roivant Sciences shares are owned by institutional investors. Comparatively, 86.2% of Harmony Biosciences shares are owned by institutional investors. 7.9% of Roivant Sciences shares are owned by company insiders. Comparatively, 30.8% of Harmony Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger valuation & earnings, ROIV or HRMY? Roivant Sciences has higher earnings, but lower revenue than Harmony Biosciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$122.59M60.80$4.35B-$0.15-69.63Harmony Biosciences$714.73M2.62$128.85M$2.5113.01 SummaryHarmony Biosciences beats Roivant Sciences on 11 of the 18 factors compared between the two stocks. Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.87B$7.25B$5.85B$8.56BDividend YieldN/A2.79%4.75%3.98%P/E Ratio15.476.2725.2219.53Price / Sales2.62197.86381.60111.72Price / Cash13.3865.6738.0534.58Price / Book4.106.547.414.39Net Income$128.85M$139.24M$3.19B$247.12M7 Day Performance-4.48%-2.78%-2.67%-2.30%1 Month Performance-15.63%-6.05%-4.39%-3.67%1 Year Performance1.68%-12.56%13.13%5.89% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.6672 of 5 stars$32.18-4.9%$53.11+65.0%+5.4%$1.85B$714.73M15.25200Earnings ReportAnalyst RevisionROIVRoivant Sciences2.3142 of 5 stars$10.52-1.5%$18.08+71.9%-8.8%$7.51B$122.59M-70.13860TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$20.93+7.3%$22.00+5.1%N/A$7.05B$516.72M0.00N/AHigh Trading VolumeRVMDRevolution Medicines4.6581 of 5 stars$41.23-0.3%$66.25+60.7%+36.7%$6.94B$11.58M-11.48250Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBBIOBridgeBio Pharma4.7065 of 5 stars$36.25-1.6%$51.67+42.5%-2.0%$6.85B$221.90M-12.72400Analyst RevisionLEGNLegend Biotech1.9622 of 5 stars$36.98-6.9%$79.50+115.0%-46.6%$6.75B$285.14M-38.931,800Positive NewsAXSMAxsome Therapeutics4.7466 of 5 stars$130.72-5.1%$158.79+21.5%+54.7%$6.37B$385.69M-21.82380Analyst ForecastBPMCBlueprint Medicines2.8663 of 5 stars$92.48+0.2%$123.83+33.9%+1.5%$5.91B$508.82M-85.63640Analyst ForecastCYTKCytokinetics3.9743 of 5 stars$48.14-4.2%$82.00+70.3%-37.8%$5.68B$7.53M-8.95250Earnings ReportAnalyst ForecastAnalyst RevisionNUVLNuvalent2.1402 of 5 stars$78.03-1.8%$113.10+44.9%-14.0%$5.54BN/A-22.4940Earnings ReportAnalyst ForecastELANElanco Animal Health3.6566 of 5 stars$11.14+1.0%$16.00+43.7%-30.2%$5.50B$4.42B27.849,300Earnings ReportAnalyst Revision Related Companies and Tools Related Companies Roivant Sciences Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Revolution Medicines Alternatives BridgeBio Pharma Alternatives Legend Biotech Alternatives Axsome Therapeutics Alternatives Blueprint Medicines Alternatives Cytokinetics Alternatives Nuvalent Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HRMY) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
